No Detail Found!

Comparison of tranexamic acid pharmacokinetics after intra-articular and intravenous administration in rabbits

Author(s)
Gen-xiang Rong Department of the joint and reconstructive microsurgery, The First Affiliated Hospital of Anhui Medical University,Hefei Anhui,PR China
Chen-lin Shen Institute for Liver Diseases of Anhui Medical University (AMU), Anhui key Laboratory of Bioactivity of Natural Products, School of pharmacy, Anhui Medical University,Hefei,PR China
Bin-jie Gui Department of the joint and reconstructive microsurgery, The First Affiliated Hospital of Anhui Medical University,Hefei Anhui,PR China
Hao Yin Chromatography and Mass Spectrometry Lab, Hefei National Laboratory for Physical Sciences at Microscale, University of Science and Technology of China,Hefei, Anhui,PR China
Zhi Tang Department of the joint and reconstructive microsurgery, The First Affiliated Hospital of Anhui Medical University,Hefei Anhui,PR China
Abstract
Tranexamic Acid (TXA) is commonly administered in total knee arthroplasty for reducing blood loss. There has been a growing interest in the topical use of TXA except intravenous use for prevention of bleeding in TKA. The aim of this study was to develop and validate a HPLC-MS method to detect TXA and apply to compare the pharmacokinetic profile of TXA after intravenous (IV) and topical intra-articular (IA) application of TXA at a dose of 20 mg/kg in rabbits. In order to prove intra-articular administration is better than that of intravenous administration from the point of rabbit pharmacokinetic. Two groups of rabbits (n=6/group) respectively received TXA intra-articularly or intravenously. Blood samples were collected at scheduled time. The concentration of TXA in plasma was determined by a validated HPLCMS method. Excellent linearity was found between 0.015 and 70.0µg/ml with a lower limit of quantitation (LLOQ) of 0.015µg/ml (r>0.99); moreover, all the validation data including accuracy and precision (intra- and inter-day) were all within the required limits. The pharmacokinetic parameters in IA and IV group were: Cmax: 30.65±3.31 VS 54.05± 6.21µg/ml (p MEC): 1.5-2.2 VS 0.7-1.2h (p<0.05). HPLC-MS method is suitable for TXA pharmacokinetic studies. The results demonstrated that topical intra-articular application of TXA showed a reduced peak plasma concentration and prolonged therapeutic drug level compared with intravenous TXA from the point of rabbit pharmacokinetic.
Publication Details
Page(s) 1309-1316
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 30, Issue: 4, Year: 2017

Request the full text from PASTIC

Keywords
Pharmacokinetics, Rabbit, tranexamic acid, intra-articular, hplc-ms
0

Citations

0

Downloads

164

Views